NCT04735978 2026-02-27
Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
Replimune Inc.
Phase 1 Active not recruiting
Clinical Trials
12 trialsNCT06422520 2026-02-23
A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors
BeOne Medicines
Phase 1 Active not recruiting
NCT04649385 2026-02-20
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors
BeOne Medicines
Phase 1 Active not recruiting
NCT05352750 2026-02-03
Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors
Sonnet BioTherapeutics
Phase 1 Active not recruiting
NCT06993116 2026-01-28
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1 Active not recruiting
NCT06328673 2025-12-24
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
D2M Biotherapeutics Inc.
Phase 1 Active not recruiting
NCT05117476 2025-11-24
MICA
Cullinan Therapeutics Inc.
Phase 1 Active not recruiting
NCT06143007 2025-11-17
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
Broadenbio Ltd., Co.
Phase 1 Active not recruiting
NCT06428500 2025-07-25
QTX3046 in Patients With KRAS G12D Mutations
Quanta Therapeutics
Phase 1 Active not recruiting
NCT04751786 2025-04-04
PRECIOUS-01
Radboud University Medical Center
Phase 1 Active not recruiting
NCT05278546 2024-11-12
A Study of ILB2109 in Patients With Advanced Solid Malignancies
Innolake Biopharm
Phase 1 Active not recruiting
NCT05621486 2023-10-12
A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors
Shanghai East Hospital
Phase 1 Active not recruiting